China Biologic Products Holdings, Inc. Amortization of Intangible Assets
China Biologic Products Holdings, Inc. reported Amortization of Intangible Assets of $8.12 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2020-03-12
- China Biologic Products Holdings, Inc. amortization of intangible assets for the quarter ending 2013-12-31 was $283.81K, a 65.55% decline year-over-year.
- China Biologic Products Holdings, Inc. amortization of intangible assets for the quarter ending 2013-09-30 was $257.32K, a 64.80% decline year-over-year.
- China Biologic Products Holdings, Inc. amortization of intangible assets for the quarter ending 2013-06-30 was $391.45K, a 46.65% decline year-over-year.
- China Biologic Products Holdings, Inc. amortization of intangible assets for the quarter ending 2013-03-31 was $282.61K, a 62.61% decline year-over-year.
- China Biologic Products Holdings, Inc. amortization of intangible assets for fiscal 2013 was $1.20M, a 60.28% decline from fiscal 2012.
- China Biologic Products Holdings, Inc. amortization of intangible assets for fiscal 2012 was $3.01M, a 7.91% decline from fiscal 2011.
- China Biologic Products Holdings, Inc. amortization of intangible assets for fiscal 2011 was $3.27M, a 8.30% decline from fiscal 2010.
- China Biologic Products Holdings, Inc. amortization of intangible assets for fiscal 2010 was $3.57M, a 6.19% increase from fiscal 2009.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $8.12M 20-F · filed 2020-03-12 | |||||
| 2018-12-31 | $8.74M 20-F · filed 2020-03-12 | |||||
| 2017-12-31 | $497.34K 20-F · filed 2020-03-12 | |||||
| 2016-12-31 | $570.29K 20-F · filed 2019-03-06 | |||||
| 2013-12-31 | $283.81K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $541.13K derived: sum of 2 quarters · filed 2014-03-12 | $932.58K derived: sum of 3 quarters · filed 2014-03-12 | $1.20M 10-K · filed 2014-03-12 | ||
| 2013-09-30 | $257.32K 10-Q · filed 2013-11-05 | $648.77K derived: sum of 2 quarters · filed 2013-11-05 | $912.47K 10-Q · filed 2013-11-05 | $1.76M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2013-06-30 | $391.45K 10-Q · filed 2013-08-06 | $655.15K 10-Q · filed 2013-08-06 | $1.50M derived: sum of 3 quarters · filed 2014-03-12 | $2.23M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2013-03-31 | $282.61K 10-Q · filed 2013-05-08 | $1.11M derived: sum of 2 quarters · filed 2014-03-12 | $1.84M derived: sum of 3 quarters · filed 2014-03-12 | $2.57M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-12-31 | $823.76K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $1.55M derived: sum of 2 quarters · filed 2014-03-12 | $2.29M derived: sum of 3 quarters · filed 2014-03-12 | $3.01M 10-K · filed 2014-03-12 | $3.09M 10-K · filed 2013-03-13 | |
| 2012-09-30 | $730.99K 10-Q · filed 2013-11-05 | $1.46M derived: sum of 2 quarters · filed 2013-11-05 | $2.19M 10-Q · filed 2013-11-05 | $2.92M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-06-30 | $733.79K 10-Q · filed 2013-08-06 | $1.46M 10-Q · filed 2013-08-06 | $1.53M 10-Q/A · filed 2012-08-27 | $2.18M derived: sum of 3 quarters · filed 2014-03-12 | $2.99M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-03-31 | $755.80K 10-Q · filed 2013-05-08 | $1.45M derived: sum of 2 quarters · filed 2014-03-12 | $2.26M derived: sum of 3 quarters · filed 2014-03-12 | $3.14M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2011-12-31 | $694.96K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $1.50M derived: sum of 2 quarters · filed 2014-03-12 | $2.39M derived: sum of 3 quarters · filed 2014-03-12 | $3.27M 10-K · filed 2014-03-12 | $3.39M 10-K · filed 2012-03-12 | |
| 2011-09-30 | $805.69K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $1.69M derived: sum of 2 quarters · filed 2012-08-27 | $2.58M 10-Q · filed 2011-11-07 | $3.53M derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-06-30 | $884.90K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-27 | $1.77M 10-Q/A · filed 2012-08-27 | $2.72M derived: sum of 3 quarters · filed 2013-03-13 | $3.60M derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-03-31 | $884.59K 10-Q · filed 2012-05-08 | $1.84M derived: sum of 2 quarters · filed 2013-03-13 | $2.71M derived: sum of 3 quarters · filed 2013-03-13 | |||
| 2010-12-31 | $951.63K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $1.83M derived: sum of 2 quarters · filed 2013-03-13 | $3.57M 10-K · filed 2013-03-13 | |||
| 2010-09-30 | $873.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $2.61M 10-Q · filed 2011-11-07 | ||||
| 2010-06-30 | $1.74M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $3.36M 10-K · filed 2012-03-12 |